✦ LIBER ✦

PCN59 Cost-Effectiveness of Pazopanib Versus Sunitinib and Bevacizumab Associated to Interferon Alpha As First Line Treatments for Metastatic Renal Cell Carcinoma

✍ Scribed by Pepe, C.; Paladini, L.; Sedlmayer, C.; Machado, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN70 COST EFFECTIVENESS ANALYSIS OF SUN

✍ E Remák; H Vioix; R Sandin; U Harmenberg; A Ullén; P Sandström 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Cost-Effectiveness And Cost-Utility Anal

✍ Torres Toala, F.G.; Albuja Riofrio, M.F.; Mould, J.F.; Estévez, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCN13 A COMPARATIVE EFFECTIVENESS ASSESS

✍ GH Mickisch; B Schwander; B Escudier; J Bellmunt; P Maroto; C Porta; S Walzer; U 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PCN26 COST-EFFECTIVENESS AND COST-UTILIT

✍ Salinas-Escudero, G; Contreras-Hernandez, I; Mould-Quevedo, J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PCN32 ECONOMIC EVALUATION OF SUNITINIB,

✍ D Greenberg 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

PUK17 Cost-Mimimization Analysis of Pazo

✍ M. Sura; S. Goryaynov; M. Avxentyeva; V. Omelyanovsky 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB